lexoro Group is a specialist in intelligent automation through the use of the latest artificial intelligence and software engineering technology. The company prides itself on being a catalyst, designer, and solution provider for innovative technology issues and their effective implementation. With over 20 years of experience, lexoro has been developing solutions for renowned companies in the pharmaceutical, medical technology, and chemical industries, accelerating regulatory workflows. The company's focus is on delivering customized projects with a keen eye on customer benefits, always emphasizing return on investment, rapid results with rapid prototyping, and vendor-independent solution development. Lexoro's unique selling points include 20 years of innovation experience in future technologies such as RPA, NLP, NLG, Machine Learning, and Data Science. They also combine technological, industry-specific, and domain expertise under one roof, with a specialization in regulated product markets like pharmaceuticals, medical technology, life science, and chemical and food industries. The company excels in automating simple and complex processes for the focus areas of texts, documents, data, and information. Founded in 2017 and headquartered in Germany, lexoro Group operates in the industries of AI and Information Technology, positioning itself at the forefront of cutting-edge technological advancements. With a track record of delivering tangible results in the market through classical and intelligent use cases, lexoro is equipped to help businesses swiftly identify suitable processes and workflows to automate.
There is no investment information
No recent news or press coverage available for lexoro Group.